Janux Therapeutics, Inc. (JANX) Social Stream

Janux Therapeutics, Inc. (JANX): $13.84

0.18 (+1.32%)

POWR Rating

Component Grades













Add JANX to Watchlist
Sign Up

Industry: Biotech


of 402

in industry

Janux Therapeutics Inc (JANX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Janux Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 3 $35 $35 $35 $14.34 144.07%
2022-03-29 3 $35 $29 $32 $14.34 123.15%

The Trend in the Analyst Price Target

Over the past 29 weeks, JANX's average price target has gone down $3.

Over the past 37 weeks, JANX's average upside potential has been 36.55%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-10 NA 35 35 35 27.79 25.94%
2021-07-24 NA 35 35 35 30.51 14.72%
2021-08-13 3 35 35 35 30.51 14.72%
2021-11-19 3 35 35 35 17.88 95.75%
2022-03-29 3 35 29 32 14.35 123%

JANX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Janux Therapeutics Inc's variance in analysts' estimates is lower than 79.06% of all US stocks.
  • In terms of how Janux Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 22.3% of that group.
  • JANX has a greater average analyst price target than 147.16% of stocks in the small market cap category.
  • Janux Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 120.44% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Janux Therapeutics Inc are IVA, ITRM, and INZY.

Is JANX a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4416 seconds.